Early research (Phase 1)Active Not RecruitingNCT05718557What this trial is testingStudy of PYX-106 in Solid TumorsWho this might be right forSolid Tumor Pyxis Oncology, Inc 47
Early research (Phase 1)Not Yet RecruitingNCT07807345What this trial is testingPhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticWho this might be right forHead & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more Sutro Biopharma, Inc. 285
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439201What this trial is testingTesting Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+2 more National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT05130255What this trial is testingGD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2Who this might be right forSCLCMalignant MelanomaSarcoma+1 more Y-mAbs Therapeutics 23
Testing effectiveness (Phase 2)Study completedNCT04669899What this trial is testingStudy of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid TumorsWho this might be right forCancer Jounce Therapeutics, Inc. 190
Early research (Phase 1)Active Not RecruitingNCT04606433What this trial is testingPhase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic Leukemia Sichuan Baili Pharmaceutical Co., Ltd. 47
Not applicableStudy completedNCT02770326What this trial is testingSafety of Stool Transplant for Patients With Difficult to Treat C. Difficile InfectionWho this might be right forC. Difficile InfectionCancer Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Ended earlyNCT02082626What this trial is testingStudy of Eribulin in Children With Cancer to Determine SafetyWho this might be right forPediatric CancerSolid TumorsLymphoma University of Oklahoma 3
Early research (Phase 1)Study completedNCT00993044What this trial is testingVincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginWho this might be right forRefractory Solid Tumors in Children Children's Hospital Los Angeles 13
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Early research (Phase 1)Study completedNCT03247309What this trial is testingTCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)Who this might be right forSolid TumorCancerRecurrent Solid Tumors+1 more Immatics US, Inc. 7
Early research (Phase 1)UnknownNCT00004036What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more The Cleveland Clinic 30
Early research (Phase 1)Study completedNCT00053963What this trial is testingFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT01703481What this trial is testingEvaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or LymphomaWho this might be right forTumor or Lymphoma Janssen Research & Development, LLC 188
Early research (Phase 1)Study completedNCT02780804What this trial is testingEntinostat in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsWho this might be right forBrain Stem NeoplasmPineal Region NeoplasmRecurrent Lymphoma+7 more National Cancer Institute (NCI) 21
Not applicableLooking for participantsNCT06404528What this trial is testingLow-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid TumoursWho this might be right forSolid Tumors, Adult Wuxi People's Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT05572684What this trial is testingA Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsMicrosatellite Instability LowMicrosatellite Instability High+9 more NextCure, Inc. 97
Testing effectiveness (Phase 2)Study completedNCT00407433What this trial is testingClinical Studies of Gemcitabine-OxaliplatinWho this might be right forMedulloblastomaCentral Nervous System TumorsNeuroblastoma+1 more Gustave Roussy, Cancer Campus, Grand Paris 156
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58